The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Senior leaders within the finance/supply chain and risk management disciplines share their thoughts on the organizational and patient risks related…
On-Demand Educational Webinars
COVID-19 has forced us all to embrace and rely on virtual technology to conduct business. This sudden change has impacted supply chain operations and…
On-Demand Educational Webinars
In the first half of the webinar, we will explore the Hospital PMI™, an ISM®<
White Papers
Explore your organization’s clinical integration maturity and leverage leadership involvement to make data-driven decisions.
White Papers
This paper shares the experience of a true and complete integration of supply chain in a mid-sized IDN under an accelerated timeline. The stud
Toolkits/Methodology
As providers begin to pivot from this pandemic back to a standard model of care, now is the time for product and service suppliers to begin…